This retrospective, 3-year follow-up study analyzed clinical outcomes and overall treatment costs in two cohorts of NSCLC patients recruited in 2017 and 2019. In real-life oncology practice, the study linked the 2019 cancer cohort to a significant improvement in cancer-specific survival, accompanied by only a slight increase in patient management costs. It was observed an increase in the costs of drug administration, outpatient services, medical devices and conversely in a decrease in hospital and hospice care costs. These results are likely related to changes in the care protocols implemented during that period.
NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts' Study
Buja, Alessandra;Rea, Federico;Zanovello, Anna;Pasello, Giulia;Guarneri, Valentina;
2025
Abstract
This retrospective, 3-year follow-up study analyzed clinical outcomes and overall treatment costs in two cohorts of NSCLC patients recruited in 2017 and 2019. In real-life oncology practice, the study linked the 2019 cancer cohort to a significant improvement in cancer-specific survival, accompanied by only a slight increase in patient management costs. It was observed an increase in the costs of drug administration, outpatient services, medical devices and conversely in a decrease in hospital and hospice care costs. These results are likely related to changes in the care protocols implemented during that period.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
